title: Opioid receptor and calcium channel regulation of adenylyl cyclase, modulated by GM1, in NG108-15 cells: competitive interactions.
abstract: GM1 ganglioside was previously shown to function as a specific regulator of excitatory opioid activity in dorsal root ganglion neurons and F11 hybrid cells, as seen in its facilitation of opioid-induced activation of adenylyl cyclase and its ability to dramatically reduce the threshold opioid concentration required to prolong the action potential duration. The elevated levels of GM1 resulting from chronic opioid exposure of F11 cells were postulated to cause the ensuing opioid excitatory supersensitivity. We now show that GM1 promotes opioid (DADLE)-induced activation of adenylyl cyclase in NG108-15 cells which possess the delta-type of receptor. In keeping with previous studies of other systems, this can be envisioned as conformational interaction of GM1 with the receptor that results in uncoupling of the receptor from Gi and facilitated coupling to Gs. This would also account for the observation that DADLE-induced attenuation of forskolin-stimulated adenylyl cyclase was reversed by GM1, provided the cells were not pretreated with pertussis toxin. When the cells were so pretreated, GM1 evoked an unexpected attenuation of forskolin-stimulated adenylyl cyclase attributed to GM1-promoted influx of calcium which was postulated to inhibit a calcium-sensitive form of adenylyl cyclase. This is concordant with several studies showing GM1 to be a potent modulator of calcium flux. Pertussis toxin in these experiments exerted dual effects, one being to promote interaction of the delta-opioid receptor with Gs through inactivation of Gi, and the other to enhance the GM1-promoted influx of calcium by inactivation of Go; the latter is postulated to function as constitutive inhibitor of the relevant calcium channel. NG108-15 cells thus provide an interesting example of competitive interaction between two GM1-regulated systems involving enhancement of both opioid receptor excitatory activity and calcium influx.
authors.affiliation: Dept of Neurosciences, New Jersey Medical School, UMDNJ, Newark 07103, USA.
authors.forename: G
authors.initials: G
authors.lastname: Wu
authors.forename: Z H
authors.initials: ZH
authors.lastname: Lu
authors.forename: P
authors.initials: P
authors.lastname: Alfinito
authors.forename: R W
authors.initials: RW
authors.lastname: Ledeen
mesh_terms: D037361:Adenylate Cyclase Toxin; D000262:Adenylyl Cyclases / Q000378:metabolism*; D000630:Aminopterin / Q000494:pharmacology; D001667:Binding, Competitive; D015220:Calcium Channels / Q000502:physiology*; D002772:Cholera Toxin / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism; D016308:Enkephalin, Leucine-2-Alanine / Q000494:pharmacology; D005456:Fluorescent Dyes; D005677:G(M1) Ganglioside / Q000494:pharmacology*; D005910:Glioma / Q000201:enzymology*; D006822:Hybrid Cells; D019271:Hypoxanthine / Q000494:pharmacology; D009447:Neuroblastoma / Q000201:enzymology*; D037342:Pertussis Toxin; D011957:Receptors, Opioid / Q000502:physiology*; D013936:Thymidine / Q000494:pharmacology; D014407:Tumor Cells, Cultured; D010566:Virulence Factors, Bordetella / Q000494:pharmacology
chemical_list: D037361:Adenylate Cyclase Toxin; D015220:Calcium Channels; D005456:Fluorescent Dyes; D011957:Receptors, Opioid; D010566:Virulence Factors, Bordetella; D019271:Hypoxanthine; D005677:G(M1) Ganglioside; D016308:Enkephalin, Leucine-2-Alanine; D002772:Cholera Toxin; D000242:Cyclic AMP; D037342:Pertussis Toxin; D000262:Adenylyl Cyclases; D000630:Aminopterin; D013936:Thymidine